Coextruded barrier structure helps commercialize new drug delivery system

Problem

With an increasing number of liquid (injectable) pharmaceutical therapies in development, drug companies are constantly on the lookout for packaging and device pairings that will improve the quality of patient care and drug efficacy. Oftentimes these specialty pharmaceuticals target therapies for cancer, autoimmune disease, diabetes, etc. The objective is to put more convenience in patient hands (via wearable devices) in order to minimize doctor office and hospital visits and improve therapeutic impact.

Tekni-Plex creates structures that offer the stability required by liquid drugs.

Learn how the right coextruded barrier structure helped commercialize a new drug delivery system:

  • Performance/stability
  • Low extractables/leachables
  • Improving functionality
  • Easy film conversion into fluid reservoirs
Coextruded barrier structure helps commercialize new drug delivery system

Performance/stability, low extractables/leachables, improving functionality, easy film conversion into fluid reservoirs

Please provide

    I consent to receive digital communications (including email and social media posts) from TekniPlex, Inc. and its direct and indirect subsidiaries (“TekniPlex”). I understand that I may revoke this consent and/or or opt-out of receiving communications from TekniPlex at any time by using the unsubscribe link provided in TekniPlex’s email communications or by choosing to unfollow TekniPlex on social media.